103 related articles for article (PubMed ID: 15252161)
1. Metabolic effects of amino acid solutions infused for renal protection during therapy with radiolabelled somatostatin analogues.
Barone R; Pauwels S; De Camps J; Krenning EP; Kvols LK; Smith MC; Bouterfa H; Devuyst O; Jamar F
Nephrol Dial Transplant; 2004 Sep; 19(9):2275-81. PubMed ID: 15252161
[TBL] [Abstract][Full Text] [Related]
2. 86Y-DOTA0)-D-Phe1-Tyr3-octreotide (SMT487)--a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion.
Jamar F; Barone R; Mathieu I; Walrand S; Labar D; Carlier P; de Camps J; Schran H; Chen T; Smith MC; Bouterfa H; Valkema R; Krenning EP; Kvols LK; Pauwels S
Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):510-8. PubMed ID: 12582815
[TBL] [Abstract][Full Text] [Related]
3. Therapy using labelled somatostatin analogues: comparison of the absorbed doses with 111In-DTPA-D-Phe1-octreotide and yttrium-labelled DOTA-D-Phe1-Tyr3-octreotide.
Barone R; Walrand S; Konijnenberg M; Valkema R; Kvols LK; Krenning EP; Pauwels S; Jamar F
Nucl Med Commun; 2008 Mar; 29(3):283-90. PubMed ID: 18349800
[TBL] [Abstract][Full Text] [Related]
4. Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine.
Rolleman EJ; Valkema R; de Jong M; Kooij PP; Krenning EP
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):9-15. PubMed ID: 12483404
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine tumors. Peptide receptor radionuclide therapy.
Forrer F; Valkema R; Kwekkeboom DJ; de Jong M; Krenning EP
Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):111-29. PubMed ID: 17382268
[TBL] [Abstract][Full Text] [Related]
6. Amino acid metabolism during total parenteral nutrition in healthy volunteers: evaluation of a new amino acid solution.
Berard MP; Hankard R; Cynober L
Clin Nutr; 2001 Oct; 20(5):407-14. PubMed ID: 11534935
[TBL] [Abstract][Full Text] [Related]
7. Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.
Putzer D; Gabriel M; Henninger B; Kendler D; Uprimny C; Dobrozemsky G; Decristoforo C; Bale RJ; Jaschke W; Virgolini IJ
J Nucl Med; 2009 Aug; 50(8):1214-21. PubMed ID: 19617343
[TBL] [Abstract][Full Text] [Related]
8. Effects of intravenous amino acid administration with Y-90 DOTA-Phe1-Tyr3-Octreotide (SMT487[OctreoTher) treatment.
Bushnell D; Menda Y; O'Dorisio T; Madsen M; Miller S; Carlisle T; Squires S; Kahn D; Walkner W; Connolly M; O'Dorisio S; Karwal M; Ponto J; Bouterfa H
Cancer Biother Radiopharm; 2004 Feb; 19(1):35-41. PubMed ID: 15068609
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Nausea and Vomiting Associated With Amino Acid Formulations Coinfused With Peptide Receptor Radionuclide Therapy: Commercial Parenteral Nutrition Formulas Versus Compounded Arginine/Lysine.
Al-Toubah T; Sikaria D; Jesurajan J; Bottiglieri S; Smith J; Pellé E; Hutchinson T; Strosberg J; El-Haddad G
Pancreas; 2021 Apr; 50(4):513-515. PubMed ID: 33939662
[TBL] [Abstract][Full Text] [Related]
10. Acute amino acid nephrotoxicity.
Zager RA; Johannes G; Tuttle SE; Sharma HM
J Lab Clin Med; 1983 Jan; 101(1):130-40. PubMed ID: 6401314
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Safety, Biodistribution, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog 177 Lu-DOTA-EB-TATE With and Without Amino Acid Infusion.
Jiang Y; Liu Q; Wang G; Zhang J; Zhu Z; Chen X
Clin Nucl Med; 2023 Jun; 48(6):e289-e293. PubMed ID: 37075254
[TBL] [Abstract][Full Text] [Related]
12. 90Y-DOTA-D-Phe1-Try3-octreotide in therapy of neuroendocrine malignancies.
Paganelli G; Bodei L; Handkiewicz Junak D; Rocca P; Papi S; Lopera Sierra M; Gatti M; Chinol M; Bartolomei M; Fiorenza M; Grana C
Biopolymers; 2002; 66(6):393-8. PubMed ID: 12658726
[TBL] [Abstract][Full Text] [Related]
13. Effect of amino acid infusion on potassium serum levels in neuroendocrine tumour patients treated with targeted radiopeptide therapy.
Giovacchini G; Nicolas G; Freidank H; Mindt TL; Forrer F
Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1675-82. PubMed ID: 21553088
[TBL] [Abstract][Full Text] [Related]
14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
15. Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients.
Faggiano A; Tavares LB; Tauchmanova L; Milone F; Mansueto G; Ramundo V; De Caro ML; Lombardi G; De Rosa G; Colao A
Clin Endocrinol (Oxf); 2008 Nov; 69(5):756-62. PubMed ID: 18485119
[TBL] [Abstract][Full Text] [Related]
16. Renal function after cardiopulmonary bypass surgery in patients with impaired renal function. A randomized study of the effect of nifedipine.
Witczak BJ; Hartmann A; Geiran OR; Bugge JF
Eur J Anaesthesiol; 2008 Apr; 25(4):319-25. PubMed ID: 18182121
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Interaction of Amino Acid Infusion on
Puszkiel A; Bauriaud-Mallet M; Bourgeois R; Dierickx L; Courbon F; Chatelut E
Clin Pharmacokinet; 2019 Feb; 58(2):213-222. PubMed ID: 29736841
[TBL] [Abstract][Full Text] [Related]
18. Effect of somatostatin analogue octreotide on pain relief after major abdominal surgery.
Dahaba AA; Mueller G; Mattiassich G; Rumpold-Seitlinger G; Bornemann H; Rehak PH; Linck G; Mischinger HJ; Metzler H
Eur J Pain; 2009 Sep; 13(8):861-4. PubMed ID: 19084439
[TBL] [Abstract][Full Text] [Related]
19. Description of a transient proximal tubulopathy induced by amino acids perfusion in peptide receptor radionuclide therapy: A case report.
Lenain R; Hamroun A; Lion G; Chamley P; Bui L; Lionet A; Hazzan M; Provôt F
Medicine (Baltimore); 2019 Dec; 98(52):e18478. PubMed ID: 31876733
[TBL] [Abstract][Full Text] [Related]
20. Treatment with (90)Y- and (177)Lu-DOTATOC in patients with metastatic neuroendocrine tumors.
Frilling A; Weber F; Saner F; Bockisch A; Hofmann M; Mueller-Brand J; Broelsch CE
Surgery; 2006 Dec; 140(6):968-76; discussion 976-7. PubMed ID: 17188146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
